Cardiac rhythm management and ablation devices require robust and clinically relevant data before they reach patients. Pharmaron offers preclinical testing solutions for: > Cardiac and peripheral ablation > Advanced pulse field ablation (PFA) > High-resolution electrical mapping Our team brings precision and experience to every electrophysiology study—ensuring reliable, translatable results. Discover our EP capabilities: https://lnkd.in/dmwPqq-E #Pharmaron #EPDevices #MedicalTechnology #CardiacAblation #ScientificExcellence
About us
Pharmaron: Global Life Sciences Services Provider Stock Code: 300759.SZ/3759.HK Founded in 2004, Pharmaron is a premier life sciences service provider that offers a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. Pharmaron’s Comprehensive CRO & CDMO Services • Synthetic, Medicinal, and Analytical Chemistry Services • Biology Services (e.g., in vitro screening, structural biology, biomarkers) • DMPK Services (e.g., in vitro ADME, in vivo PK, PKPD, mass balance) • Pharmacology Services (e.g., in vivo pharmacology, animal disease models, immunotoxicity) • Drug Safety Assessment Services (e.g., toxicology, safety pharmacology, genetic toxicology) • Radiochemistry and Isotopically Labelled Metabolism Services (e.g., 14C/Carbon-14 radiosynthesis, 3H/tritium radiosynthesis, QWBA, mARG) • CMC Services (e.g., API manufacturing, process chemistry, formulation development) • Clinical Development Services (e.g., First-in-Human [FIH], ethnobridging, microdosing Phase 0, absolute bioavailability) Commitment to Excellence and Innovation With a proven track record of success, Pharmaron continually invests in its people, facilities, and technologies to meet evolving scientific and regulatory demands. The company prides itself on enabling scientific breakthroughs and supporting its partners in advancing human health. ____________________________________ Learn More: Explore Pharmaron’s services to discover how to accelerate your R&D programs. www.pharmaron.com. ________________________________________ Keywords: CRO, CDMO, synthetic chemistry, medicinal chemistry, biology, radiochemistry, toxicology, First-in-Human, API manufacturing, PKPD, 14C radiosynthesis, discovery biologics, clinical development, small molecules, biologics, cell and gene therapy (CGT) products
- Website
-
http://www.pharmaron.com
External link for Pharmaron
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Beijing
- Type
- Privately Held
- Founded
- 2004
- Specialties
- Chemistry, Biology, DMPK, Pharmacology, Chemical Development, Preclinical, Toxicology, Safety Pharmacology, Discovery, Lead Optimization, Process Development, Assay Development, ADME, Formulation, clinical pharmacology, analytical sciences, radiolabelled chemistry, accelerator mass spectrometry, radiolabelled compounds, API manufacturing, radiosynthesis, Biologics, CGT , cell and gene therapy, synthetic chemistry, medicinal chemistry, radiochemistry, PKPD, and small molecule
Locations
Employees at Pharmaron
Updates
-
The science behind the fields of biologics and cell and gene therapy (CGT) changes rapidly. Pharmaron's BioInnovate Digest is how you keep up. The new newsletter issue is here! You can read up on the latest insights on biologics and cell and gene therapy and learn what's shaping development strategy. Download recent posters from ASGCT and PEGs to gain perspectives about what teams across process development, analytical testing, clinical production, and commercial manufacturing need to know right now. This is the kind of signal-to-noise ratio the industry needs more of. If your work touches CGT or biologics at any stage, this one's for you. Read the latest issue and subscribe to get every future edition delivered directly to you. The future of drug development doesn't wait. Neither should your intel. #Pharmaron #Innovation #biologics #cgt #cellandgenetherapy #EmergingModalities #PharmonNews #BiotechNews #PharmaInnovation #FutureOfMedicine #SubscribeNow #ShareTheKnowledge Pharmaron Biologics and Cell & Gene Therapy
-
Accelerate your IND journey with Pharmaron’s end-to-end support. > Expertise in toxicology and CMC services > GMP and non-GMP manufacturing to match your project needs > Strategic guidance for faster, smoother submissions. Learn how we can help: https://lnkd.in/dCsrN6Md #Biologics #INDEnabling #Pharmaron #DrugDevelopment #RegulatorySupport #cGMPManufacturing #AcceleratedDevelopment
-
-
Located near Newcastle Upon Tyne, UK, our Cramlington site is a key hub for 𝐜𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐀𝐏𝐈 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠, offering scalable solutions from 10L to 10,000L across GMP and non-GMP environments. 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: - 100,000L of vessel & isolation equipment - MHRA, FDA, EMA, PDMA regulatory compliance - Controlled drug licenced – all schedules - OEB 4 containment & expanding QC capabilities - Integrated within the One-Pharmaron global CMC network With 𝟏𝟕𝟕,𝟎𝟎𝟎 𝐟𝐭² of advanced infrastructure and deep expertise in tech transfer, Cramlington is built for seamless scale-up—from 1kg to metric ton production. Learn more about our Cramlington site: https://lnkd.in/dYwZRz9G #PharmaronSpotlight #APIManufacturing #PharmaronCramlington #CDMO
-
-
𝐍𝐄𝐖 𝐖𝐄𝐁𝐈𝐍𝐀𝐑 Pharmaron’s BioInnovate Webinar Series, formerly focused on CGT, has expanded to cover a broader range of topics supported by our multi-modality expertise, touching on discovery, process development, bioanalysis, analytical testing, commercial manufacturing, specialized therapeutic areas, and more! Join us for our upcoming session on Wednesday, June 3 at 11AM ET: “𝐓𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐎𝐜𝐮𝐥𝐚𝐫 𝐌𝐞𝐥𝐚𝐧𝐨𝐦𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬" Speakers: > 𝐒𝐚𝐧𝐝𝐞𝐞𝐩 𝐊𝐮𝐦𝐚𝐫, 𝐏𝐡𝐃, Director of Ophthalmology, Pharmaron > 𝐀𝐫𝐮𝐧 𝐒𝐢𝐧𝐠𝐡, 𝐌𝐃, Director, Department of Ophthalmic Oncology, Cleveland Clinic This expert-led discussion will explore key preclinical and translational considerations in advancing ocular melanoma therapies. Register Below!
-
Pharmaron's Chemistry for Life Science Symposium is well underway, and what a day it has been so far! The symposium has a distinct learning culture, which evolves from our deep commitment to our employees, partners, and collaborators in supporting success in discovery, development and commercialization of innovative medicines. We've heard from Prof. James A Bull, Dr. Martin Rosenberg, Prof. Michael Willis and Dr. Martin Stockley so far, and we've got some amazing talks still to come! If you've missed out on attending today's event, please click here for more information on Pharmaron's upcoming events: https://lnkd.in/gsYxSFd3
-
-
𝐃𝐚𝐲 𝟏 𝐚𝐭 #CDMOLive 𝐢𝐧 𝐑𝐨𝐭𝐭𝐞𝐫𝐝𝐚𝐦 𝐢𝐬 𝐛𝐮𝐳𝐳𝐢𝐧𝐠! Want to learn how Pharmaron supports faster progression from discovery to development? Come by and chat with us. 📍 𝐂𝐨𝐦𝐞 𝐬𝐚𝐲 𝐡𝐞𝐥𝐥𝐨 𝐚𝐭 𝐒𝐭𝐚𝐧𝐝 𝐒𝟏𝟕 Meet Nicolas Duchemin, Tara Hope & Javier Ruiz Sanz #CDMO #Biotech #Development #API
-
-
Happy International Clinical Trials Day! 🎉 Today, we celebrate the incredible work and dedication of researchers, healthcare professionals, coordinators, data analysts, and volunteers who make clinical trials possible. Clinical trials are the pillar of medical advancements, turning innovative ideas into safe and effective treatments. They bring hope to millions of people and pave the way for future breakthroughs in medicine. Also, a special thank you to the volunteers who participate in these trials, offering their time and trust to advance science and improve healthcare. Their commitment and contribution are invaluable. We want to especially shine a light on all those Pharmaron team members who work at our clinical facilities across the US and China. Your hard work and dedication ensure the highest standards of research and patient care. Learn more about clinical development at Pharmaron - https://lnkd.in/d-KazMPg #CTD2026 #ClinicalTrialsDay #MedicalResearch #PatientCare #ResearchHeroes #ClinicalResearch #ClinicalTrials #bioanalysis #clinicalanalysis
-
-
When is infusion the optimal choice for drug dosing in animal studies? Pharmaron’s latest insights guide researchers in selecting the best methods for pharmacokinetic precision. Infusion allows for steady drug levels, reducing variability and enhancing study outcomes. Download our flyer to learn more: [https://lnkd.in/dGZD6FvN] #Pharmacokinetics #DrugDelivery #DrugDiscovery #DrugDevelopment #Pharmaron
-
At Pharmaron, our 𝐨𝐜𝐮𝐥𝐚𝐫 𝐭𝐢𝐬𝐬𝐮𝐞 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 provide critical insights into drug permeability and formulation performance—without the need for in vivo studies. Using 𝐞𝐱 𝐯𝐢𝐯𝐨 𝐚𝐧𝐝 𝐢𝐧 𝐯𝐢𝐭𝐫𝐨 𝐦𝐨𝐝𝐞𝐥𝐬, we evaluate: > Permeation across rabbit & human cornea > 3D tissue constructs for high-throughput screening > Bioequivalence of generics vs. RLDs > Formulation optimization with excipients Our team designs and validates 𝐈𝐕𝐏𝐓 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 with precision—covering analytical conditions, dose selection, and statistical evaluation across multiple donors. Whether you're developing a new topical therapy or comparing generics, Pharmaron delivers 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲-𝐫𝐞𝐚𝐝𝐲 𝐝𝐚𝐭𝐚 to guide your formulation strategy. Learn more below! #OcularTesting #IVPT #Bioequivalence #Pharmaron #TopicalFormulation #DrugDelivery #Ophthalmology #ExVivoModels #InVitroTesting #PharmaInnovation
-